iShares IV - iShares NASDAQ US Biotechnology UCITS ETF (OTCPK:IVBU.F) - Stock Price, News & Analysis

IVBU.F Stock Overview

An exchange traded fund launched by BlackRock Asset Management Ireland Limited.

IVBU.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for iShares IV - iShares NASDAQ US Biotechnology UCITS ETF
Historical stock prices
Current Share Price	US$6.42
52 Week High	US$6.50
52 Week Low	US$5.38
Beta	0
1 Month Change	5.96%
3 Month Change	2.80%
1 Year Change	10.50%
3 Year Change	-3.28%
5 Year Change	n/a
Change since IPO	25.70%

Recent updates

Shareholder Returns

	IVBU.F	US Capital Markets	US Market
7D	2.0%	-0.6%	-0.2%
1Y	10.5%	39.9%	28.2%

Return vs Industry: IVBU.F underperformed the US Capital Markets industry which returned 39.9% over the past year.

Return vs Market: IVBU.F underperformed the US Market which returned 28.2% over the past year.

Price Volatility

Is IVBU.F's price volatile compared to industry and market?
IVBU.F volatility
IVBU.F Average Weekly Movement	n/a
Capital Markets Industry Average Movement	3.3%
Market Average Movement	5.9%
10% most volatile stocks in US Market	16.0%
10% least volatile stocks in US Market	2.8%

Stable Share Price: IVBU.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine IVBU.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	n/a	www.ishares.com/uk/individual/en/products/291450/

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States.

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Fundamentals Summary

How do iShares IV - iShares NASDAQ US Biotechnology UCITS ETF's earnings and revenue compare to its market cap?
IVBU.F fundamental statistics
Market cap	US$481.49m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is IVBU.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IVBU.F income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IVBU.F perform over the long term?

See historical performance and comparison

iShares IV - iShares NASDAQ US Biotechnology UCITS ETF OTCPK:IVBU.F Stock Report